INVESTMENTS (Details Narrative)										1 Months Ended	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 03, 2021 shares	Jul. 22, 2021 USD ($) shares	May 13, 2021 USD ($)	Apr. 01, 2021 USD ($) $ / shares	Mar. 18, 2021 USD ($) shares	Mar. 15, 2021 $ / shares shares	Dec. 19, 2020 USD ($) shares	Sep. 10, 2020 USD ($)	Jun. 25, 2020 shares	Sep. 30, 2021 USD ($) shares	Dec. 31, 2021 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2021 USD ($) shares	Dec. 31, 2020 USD ($) shares	Dec. 31, 2019 USD ($) shares	Jun. 18, 2021	Dec. 31, 2018 $ / shares shares	Dec. 31, 2018 $ / shares shares	Oct. 31, 2017 $ / shares
Class of Warrant or Right, Outstanding | shares									1,271,792.91
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised | shares									1,291,000
Investments and Other Noncurrent Assets											$ 11,001,000	$ 11,001,000	$ 11,001,000	$ 1,788,000	$ 2,154,000
Warrants percentage														7.00%
Unrealized Gain (Loss) on Investments													1,544,000	$ 3,851,000
Number of common stock issued, value													121,780,000	20,195,000
Investments equity method											1,080,000	1,080,000	1,080,000	12,234,000
Shares Issued, Price Per Share | $ / shares																			$ 0.15
Investments											4,341,000	4,341,000	$ 4,341,000	1,056,000
Debt Instrument, Maturity Date													May 31, 2022
Debt Instrument, Interest Rate, Stated Percentage																4.25%
Vivacitas Agreement [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares		1,000,000
Stock Issued During Period, Value, Stock Options Exercised		$ 1,000,000
Security Purchase Agreement [Member]
Investments equity method										$ 1,400,000
Convertible note										1,400,000
Origination fee										$ 500,000
Debt Instrument, Maturity Date										Sep. 09, 2024
Debt Instrument, Interest Rate, Stated Percentage										10.00%
Security Purchase Agreement [Member] | GTNW [Member]
Unrealized Gain (Loss) on Investments											1,200,000	3,300,000
Beginning balance, shares | shares										154,173
Membership Unit Purchase Agreement [Member]
Unrealized Gain (Loss) on Investments												59,629
Payments to Acquire Equity Method Investments										$ 1,537,000
Common Stock [Member]
Number of common stock issued, value													$ 1,347,000	$ 68,000
Beginning balance, shares | shares	12,156,000												67,340,000	3,434,000
BMI Capital International LLC [Member]
Investments equity method											$ 19,000	$ 19,000	$ 19,000
Impact Oncology PTE Ltd [Member]
Options to purchase additional shares | shares					250,000
Business Combination, Consideration Transferred					$ 2,480,000
Sentinel Brokers Company Inc [Member]
Ownership, percentage			50.10%
Business Combination, Consideration Transferred			$ 300,000
Investments			$ 750,000
Outstanding Remaining Membership Interest			25.00%
DSS Securities, Inc. [Member]
Ownership, percentage								14.90%
BMI Capital International LLC [Member]
Ownership, percentage										24.90%
BMI Capital International LLC [Member] | Maximum [Member]
Ownership, percentage											20.00%	20.00%	20.00%
BioMed Technologies Asia Pacific Holdings Limited [Member]
Ownership, percentage							4.99%
Vivacitas Agreement [Member]
Ownership, percentage											16.00%	16.00%	16.00%
Sentinel Brokers Company Inc [Member]
Ownership, percentage			24.90%
Security Purchase Agreement [Member]
Equity Method Investment, Description of Principal Activities													In September 2021, the SHRG, Stemtech Corporation (“Stemtech”) and Globe Net Wireless Corp. (“GNTW”) entered into a Securities Purchase Agreement (the “SPA”) pursuant to which the SHRG invested $1.4 million in Stemtech in exchange for: (a) a Convertible Promissory Note in the amount of $1.4 million in favor of the SHRG (the “Convertible Note”) and (b) a detachable Warrant to purchase shares of GNTW common stock (the “GNTW Warrant”). Stemtech is a subsidiary of GNTW. As an inducement to enter into the SPA, GNTW agreed to pay to the SHRG an origination fee of $500,000, payable in shares of GNTW’s common stock. The Convertible Note matures on September 9, 2024, bears interest at the annual rate of 10%, and is convertible, at the option of the holder, into shares of GNTW’s common stock at a conversion rate calculated based on the closing price per share of GNTW’s common stock during the 30-day period ended September 19, 2021. The GNTW Warrant expires on September 13, 2024 and conveys the right to purchase up to 1.4 million shares of GNTW’s common stock at a purchase price calculated based on the closing price per share of GTNW’s common stock during the 10-day period ended September 13, 2021.
Membership Unit Purchase Agreement [Member]
Ownership, percentage										30.75%
Alset International Limited [Member]
Investment Owned, Balance, Shares | shares																	21,196,552	21,196,552
Class of Warrant or Right, Outstanding | shares																	105,982,759	105,982,759
Class of Warrant or Right, Exercise Price of Warrants or Rights | (per share)																	$ 0.0298	$ 0.040
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised | shares															61,977,577
Total cost of warrant															$ 1,829,000
Singapore eDevelopment Limited [Member]
Marketable Securities											$ 4,909,000	$ 4,909,000	$ 4,909,000	$ 6,830,000
Unrealized Gain (Loss) on Investments													$ 1,920,000	$ 3,384,200
DSS Securities, Inc. [Member]
Number of common stock issued, value								$ 100,000
Ownership, percentage								10.00%
Acquistion description													On or about August 28, 2020, the Company’s wholly owned subsidiary, DSS Securities, Inc. entered into a corporate venture to form and operate a real estate title agency, under the name and flagging of Alset Title Company, Inc, a Texas corporation (“ATC”). DSS Securities, Inc. shall own 70% of this venture with the other two shareholders being attorneys necessary to the state application and permitting process. ATC have initiated or have pending applications to do business in a number of states, including Texas, Tennessee, Connecticut, Florida, and Illinois. For the purpose of organization and the state application process, the Company’s CEO, who is a licensed attorney, has a stated non-compensated 15% ownership interest in the venture. There was minimal activity for the year ended December 31, 2021.
BioMed Technologies Asia Pacific Holdings Limited [Member]
Number of common stock issued, value							$ 630,000
Beginning balance, shares | shares							525
Vivacitas Oncology Inc [Member]
Beginning balance, shares | shares						500,000							90,000
Options to purchase additional shares | shares						1,500,000
Shares Issued, Price Per Share | $ / shares				$ 1.00		$ 1.00
Shares Issued, Price Per Share | $ / shares						$ 1.00
Line of Credit Facility, Periodic Payment, Principal				$ 120,000
Vivacitas Oncology Inc [Member] | Common Stock [Member]
Options to purchase additional shares | shares						500,000
Shares Issued, Price Per Share | $ / shares						$ 1.00
Impact Oncology PTE Ltd [Member]
Investment Owned, Balance, Shares | shares					2,480,000